Reagents and supplies for PacBio Revio HiFi sequencing platform
ID: FDA-SSN-130433Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFFOOD AND DRUG ADMINISTRATIONFDA OFFICE OF ACQ GRANT SVCSBeltsville, MD, 20705, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/644b05126d2b4a72843fc856eab2c6d1/view
Timeline
    Description

    The U.S. Food and Drug Administration (FDA) is seeking small business sources capable of providing reagents and supplies for the PacBio Revio HiFi sequencing platform, specifically for a study on tobacco-derived nicotine mutations. The procurement aims to acquire specific items, including SMRT Cell trays, SPRQ sequencing plates, pipet tips, and SMRT Bell Adapter index plates, which are essential for conducting error-corrected next-generation sequencing as part of a 28-day subacute inhalation genotoxicity study. This initiative is critical for advancing research in genetic and molecular toxicology, particularly in relation to tobacco products. Interested vendors must submit their capability statements by July 21, 2025, to Warren Dutter at warren.dutter@fda.hhs.gov, with no contract awarded from this sources sought announcement.

    Point(s) of Contact
    Warren Dutter
    (870) 543-7577
    warren.dutter@fda.hhs.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Reagents and supplies for PacBio Revio HiFi sequencing platform
    Currently viewing
    Sources Sought
    Similar Opportunities
    Eurofin's EvoCard for DNA Sequencing
    Buyer not available
    The Department of Defense, specifically the Naval Research Laboratory (NRL), is seeking to procure EVOcards from Eurofins Genomics through a sole-source acquisition due to urgent and compelling needs. These EVOcards are essential for acquiring oligonucleotides, synthesized genes, and sequencing reactions, which are critical for ongoing research in molecular biology, biotechnology, and DNA nanotechnology. The NRL requires a rapid 24-hour turnaround for these specialized products to avoid disruptions in vital research related to biothreats and emerging diseases, with Eurofins identified as the only viable source capable of meeting this requirement. For further inquiries, interested parties can contact Brandon Zellers at brandon.zellers@nrl.navy.mil.
    EZ1 & 2 DNA Blood Isolation Kit and DNA Tissue Kit
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to negotiate a sole source contract with Qiagen for the procurement of EZ1 & 2 DNA Blood Isolation Kits and DNA Tissue Kits. These kits are critical for the ongoing clinical research and patient care at the NIH Clinical Center, particularly for Human Leukocyte Antigen (HLA) matching in transplant patients and potential donors. The kits have been extensively tested and are essential for providing high-quality DNA samples necessary for critical Next Generation Sequencing, with an estimated contract value of $29,166.25. Interested parties may submit capability statements by email to valerie.gregorio@nih.gov by 11:00 AM EST on December 13, 2025, referencing NOI-CC-26-000013.
    AB Assurance 1 PM plan for the DNA Analyzer 3730XL (UPG)
    Buyer not available
    The National Institutes of Health (NIH), specifically the Eunice Kennedy Shriver National Institute on Child Health and Human Development (NICHD), is seeking to award a sole-source contract for maintenance services for the DNA Analyzer 3730XL (UPG) from Life Technologies Corporation. The procurement involves a one-year maintenance service plan, known as the AB Assurance 1 PM plan, which is critical for ensuring the operational reliability of the DNA analyzer, a vital tool in genetic research and analysis. Interested vendors are invited to submit their quotations by December 14, 2025, at 12:00 PM EST, referencing solicitation number 75N94026Q00006, with evaluations focusing on technical capability and past performance. For further inquiries, vendors may contact Kelly Robinson at kelly.robinson@nih.gov or +1 301 435 2719.
    FDA BIMO Inspections and Compliance Support
    Buyer not available
    The U.S. Food and Drug Administration (FDA) is conducting a Sources Sought notice to identify small businesses capable of providing professional services for its Bio-Research Monitoring (BIMO) program. The FDA aims to modernize and consolidate its IT systems to enhance inspections and compliance support, requiring expertise in areas such as workflow management, data integration, and the development of a centralized BIMO database and analytics platform. This initiative is critical for improving the efficiency and effectiveness of BIMO inspections across all centers, and interested parties must submit their responses by January 5, 2026, to Michelle Dacanay at michelle.dacanay@fda.hhs.gov.
    OligoCard for DNA Sequencing
    Buyer not available
    The Department of Defense, specifically the Naval Research Laboratory (NRL), is seeking a sole-source procurement of OligoCards from Integrated DNA Technologies (IDT) for critical research purposes. This acquisition, valued between $10,000 and $250,000, is justified under FAR 13.106-1(b)(1)(i) due to the urgent need for specialized oligonucleotides and comprehensive sequencing services that only IDT can provide. The OligoCards are vital for advancing molecular biology, biotechnology, and DNA nanotechnology research, particularly in areas such as protein production, threat detection, and sensor development for the Department of Defense. Interested parties can reach out to Brandon Zellers at brandon.zellers@nrl.navy.mil for further information regarding this opportunity.
    REQUEST FOR PRE-PROPOSALS – Far Forward Biological Sequencing (Increment 2) for JPEO CBRND; Automated Sample Prep
    Buyer not available
    The Department of Defense, through the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), is soliciting pre-proposals for the Far Forward Biological Sequencing (FFBS) Increment 2 project, which aims to develop an automated biological identification system capable of detecting various Biological Warfare Agents (BWAs). The objective is to create a system that achieves a Technology Readiness Level (TRL) of seven or higher within 24 months, incorporating automated sample preparation, a nanopore sequencing device, and bioinformatics software, all operable by non-laboratory trained users in field environments. This initiative addresses critical gaps in current biological identification capabilities for military personnel in far-forward settings, enhancing their safety and operational effectiveness. Interested vendors must submit their pre-proposals by December 8, 2025, and can direct inquiries to Jessica R. Green-Farley at jessica.r.green-farley.civ@army.mil or Tyler N. Gates at tyler.n.gates2.civ@army.mil.
    GMP Manufacturing of CDC FluSC2 Multiplex EUA Kit
    Buyer not available
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), has awarded a contract for the GMP manufacturing of the CDC FluSC2 Multiplex EUA Kit to Biosearch Technologies, Inc. This contract, valued at $399,993, entails the production of 1,020 vials of oligonucleotide primers and probes, adhering to Good Manufacturing Practices (GMP) as defined under 21 CFR 820, with a required delivery date of September 25, 2023. The specific internal BHQnova quencher design of the probes is critical for the diagnostic assay, which has received Emergency Use Authorization (EUA) from the FDA, and no other suppliers have been identified that can meet these stringent requirements. For further inquiries, interested parties may contact Mark Draluck at syq1@cdc.gov or Devin Barich at uca9@cdc.gov.
    Single-Nuclei Multiome Analysis of Human Brain Tissue, iPSC-Derived Cells and Human Dorsal Root Ganglion
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified entities to conduct a Single-Nuclei Multiome Analysis of Human Brain Tissue, iPSC-Derived Cells, and Human Dorsal Root Ganglion. This procurement aims to advance research in medical laboratory testing by analyzing complex biological samples to enhance understanding of neurological conditions. The work is critical for developing innovative treatments and therapies in the field of neuroscience. Interested parties can reach out to Maggie Brant at maggie.brant@nih.gov or KJ Shaikh at KJ.Shaikh@nih.gov for further details regarding this opportunity.
    6550--Triage Meterpro Reagents
    Buyer not available
    The Department of Veterans Affairs (VA) is seeking qualified sources to provide QuidelOrtho Triage MeterPro Reagents for the New Mexico VA Healthcare System, through a Sources Sought Notice (RFI 36C26226Q0177). The procurement aims to acquire various medical diagnostic and drug testing supplies, including Triage Tox DS Panels, Controls, and BNP Test Kits, which are essential for accurate drug testing and patient care. Interested vendors are encouraged to submit their capabilities, pricing, and relevant business information by December 8, 2025, at 10:00 a.m. PST, to the Contract Specialist, Clift Domen, at Clift.Domen@va.gov.
    JPEO-CBRND RFI - Genomic Sequencing Workflows
    Buyer not available
    The Department of Defense's Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) is issuing a Request for Information (RFI) to gather insights on end-to-end untargeted genomic sequencing workflows suitable for military applications. The RFI seeks to identify industry capabilities in developing genomic sequencing workflows, field-deployable bioinformatics tools, test and evaluation infrastructure, and protein toxin sequencing capabilities, all tailored for military users with varying technical expertise. This initiative is crucial for enhancing military readiness and response to biological threats through advanced genomic technologies. Interested parties are invited to submit their responses by January 9, 2026, with an Industry Day scheduled for January 29, 2026, at the SPA, Crown Center Conference Facility in Lorton, VA. For more information and to respond, please visit the Joint Enterprise Technology Tool (JETT) page.